Tomorrow's Cure cover art

Tomorrow's Cure

Tomorrow's Cure

By: Mayo Clinic
Listen for free

About this listen

 Tomorrow’s Cure is a Mayo Clinic podcast that is bringing the future of healthcare to the present. Listen to engaging discussions with researchers, doctors and industry experts who are at the forefront of medical innovations. Learn how technology and innovation are changing the healthcare landscape, and how previously unavailable solutions are now improving or saving lives. Tomorrow’s Cure inspires deep thinking as we explore our healthcare future together.2024 Mayo Clinic Science
Episodes
  • Inside EVLP: A Revolution for Donor Organs

    Inside EVLP: A Revolution for Donor Organs
    Mar 11 2026
    For people waiting for a lung transplant, every phone call could be life changing. But too many donor lungs are still turned down. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer explores how ex vivo lung perfusion, or EVLP, is helping turn a “no” into a “maybe” and sometimes a “yes” for patients who are running out of options. Cathy talks with Mayo Clinic cardiothoracic surgeon Dr. Jack Haney and Brandi Zofkie, Associate Vice President at Lung Bioengineering, about how EVLP keeps lungs alive outside the body so experts can better evaluate and sometimes improve them before transplant. They discuss real patient impact, the logistics of making this technology available to more centers and the honest challenges that still remain. Listeners will hear why this innovation matters now and what it could mean for the future of lung transplantation, from expanding the donor pool to offering more second chances to breathe. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠ Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic
    Show More Show Less
    40 mins
  • The Quiet Beginnings of Leukemia

    The Quiet Beginnings of Leukemia
    Mar 4 2026
    Chronic lymphocytic leukemia is the most common leukemia in adults, yet its earliest warning sign often hides in plain sight. Monoclonal B cell lymphocytosis, or MBL, affects millions of adults who may never know they carry this precursor to CLL. In this episode of Tomorrow's Cure from Mayo Clinic, host Cathy Wurzer talks with hematologist Dr. Sameer Parikh and researchers Dr. Susan Slager and Dr. Gerald Marti about how MBL was discovered, what it reveals about inherited risk, and why it matters for infections, second cancers and long term health. The conversation explores how large population studies at Mayo Clinic, advanced genomics, and emerging tools like artificial intelligence and liquid biopsy could change when and how CLL is found, monitored and treated. Listeners will also hear candid discussion about ethics, anxiety and watchful waiting, and how Mayo Clinic's PreCure initiative is rethinking cancer prevention clinics for people living with early warning signs in their blood. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠ Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic
    Show More Show Less
    43 mins
  • Shortening the Diagnostic Journey: Genomics for Every Child

    Shortening the Diagnostic Journey: Genomics for Every Child
    Feb 25 2026
    When a child is critically ill and answers are elusive, every day can feel like an eternity. This week on Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with pediatric geneticist Whitney Thompson, M.D., from Mayo Clinic, genomic medicine pioneer Stephen Kingsmore, M.D., DSc, from Rady Children’s Institute for Genomic Medicine, and Sean George, Ph.D., CEO of Inflection Medicine, about how rapid whole genome sequencing is transforming care for the youngest patients. Together, they explore how clinicians are shortening the “diagnostic odyssey,” pairing sequencing with artificial intelligence to identify potential treatments, and redefining what is possible for rare diseases through programs like Mayo Clinic Children’s BabyFORce. You will also hear powerful patient stories, including children whose lives changed after a genomic diagnosis opened the door to targeted therapies, and a candid discussion about cost, access, and ethics as this technology moves toward wider adoption. Tune in to learn how today’s breakthroughs in pediatric genomics could shape the future of medicine for all of us. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: ⁠https://mayocl.in/3EcNPNc⁠ Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/⁠Follow • Mayo Clinic on Instagram: ⁠https://www.instagram.com/mayoclinic/⁠Follow • Mayo Clinic on X (formerly Twitter): ⁠https://x.com/MayoClinic⁠Follow • Mayo Clinic on Threads: ⁠https://www.threads.net/@mayoclinic
    Show More Show Less
    41 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.